Forschung in Österreich: wissenschaftliche Exzellenz und wirtschaftlicher Erfolg – wie geht das?

Competition for Knowledge - Status of #Research Funding in#Austria - Report of the Podium Discussion in derStandard.at (German) #VRVIS

Politik, Verwaltung und Wirtschaft folgen seit Jahren unisono dem gleichen Credo: wir brauchen mehr Wissenschaft und Forschung in unserem Land, um weiterhin im weltweiten Wettbewerb die Nase vorn zu haben. Doch folgen den hehren Worten auch handfeste Taten? Wie sieht ein fruchtbares Umfeld für erfolgreiche Forschung aus und findet diese in Österreich statt? Wie definieren wir im 21. Jahrhundert das Wechselspiel zwischen Grundlagenforschung und angewandter Forschung und welche Rolle darf die Wirtschaft und sollen öffentliche Mittel dabei spielen?

Im Rahmen einer Expertendiskussion aus Verwaltung, Wissenschaft und Wirtschaft werden die Schwerpunkte der heimischen Forschungspolitik erörtert.

Termin: 15. Mai 2014, 18:30

Ort:        Haus der Musik (Innenhof), Seilerstätte 30, 1010 Wien


Keynote

• Mag. Dr. Johannes Gadner, Stellvertretender Geschäftsführer, Rat für Forschung und Technologieentwicklung

Diskussion

• Dr. Michael Losch, Sektionsleiter im Bundesministerium für Wissenschaft, Forschung und Wirtschaft
• MR Mag. Ingolf Schädler, Sektionsleiter-Stv. im Bundesministerium für Verkehr, Innovation und Technologie
• Prof. Dr. Herbert Edelsbrunner, Institute of Science and Technology Austria (IST Austria)
• Franz Tiani, Agfa HealthCare, Managing Director HE/North, Central & Eastern Europe
• DI Georg Stonawski, Geschäftsführer VRVis

Moderation: Peter Illetschko, Der Standard

https://www.eventbrite.com/e/wissenschaftliche-exzellenz-und-wirtschaftlicher-erfolg-wie-geht-das-registrierung-11234652147?ref=enivtefor001&invite=NTU5MDk0Ny9pbmZvQHZydmlzLmF0LzA%3D&utm_source=eb_email&utm_medium=email&utm_campaign=inviteformalv2&utm_term=attend&ref=enivtefor001

Mobile Health (mHealth) survey conducted by EC

Recently the European Commission published the Green Paper on mobile Health ("mHealth") announced in the eHealth Action Plan 2012-20203. The purpose is to is to launch a broad stakeholder consultation on this subject. The document analyses mHealth potential to maintain and improve patients' health and well-being and encourage their empowerment. It also considers the potential of mHealth and its technological aspects and presents the issues where stakeholder input is sought. Interested parties are invited to submit their views in response to the above questions to CNECT-GREEN-PAPER-mHealth@ec.europa.eu  until 3 July 2014. 

Questions asked in the Green Paper:

• Which specific security safeguards in mHealth solutions could help to prevent unnecessary and unauthorised processing of health data in an mHealth context?
• How could app developers best implement the principles of “data minimisation” and of  "data protection by design, and “data protection by default” in mHealth apps?
• What measures are needed to fully realise the potential of mHealth generated "Big Data" in the EU whilst complying with legal and ethical requirements?
• Are safety and performance requirements of lifestyle and wellbeing apps adequately covered by the current EU legal framework?
• Is there a need to strengthen the enforcement of EU legislation applicable to mHealth by competent authorities and courts; if yes, why and how?
• What good practices exist to better inform end-users about the quality and safety of mHealth solutions (e.g. certification schemes)?
• Which policy action should be taken, if any, to ensure/verify the efficacy of mHealth solutions?
• How to ensure the safe use of mHealth solutions for citizens assessing their health and wellbeing?
• Do you have evidence on the uptake of mHealth solutions within EU's healthcare systems?
• What good practices exist in the organisation of healthcare to maximise the use of mHealth for higher quality care (e.g. clinical guidelines for use of mHealth)?
• Do you have evidence of the contribution that mHealth could make to constrain or curb healthcare costs in the EU?
• What policy action could be appropriate at EU, as well as at national, level to support equal access and accessibility to healthcare via mHealth?
• What, if anything, do you think should be done, in addition to the proposed actions of the eHealth Action Plan 2012-2020, in order to increase interoperability of mHealth solutions?
• Do you think there is a need to work on ensuring interoperability of mHealth applications with Electronic Health Records? And if yes by whom and how?
• What recommendations should be made to mHealth manufacturers and healthcare professionals to help them mitigate the risks posed by the use and prescription of mHealth solutions? 
• Could you provide specific topics for EU level research & innovation and deployment priorities for mHealth?
• How do you think satellite applications based on EU navigation systems (EGNOS and Galileo) can help the deployment of innovative mHealth solutions?
• Which issues should be tackled (as a priority) in the context of international cooperation to increase mHealth deployment and how?
• Which good practice in other major markets (e.g. US and Asia) could be implemented in the EU to boost mHealth deployment?
• Is it a problem for web entrepreneurs to access the mHealth market? If yes, what challenges do they face? How can these be tackled and by whom?
• If needed, how could the Commission stimulate industry and entrepreneurs involvement in mHealth, e.g. through initiatives such as "Startup Europe" or the European Innovation Partnership on Active and Healthy Ageing?